BrainEver

Raised $38.9M in a Series B round, announced 3 July 2025.

Total raised: $38.9M

Latest round Series BCountry FranceSector AI

Round

$38.9MSeries B, 3 July 2025

Funds a Phase I/II ALS clinical trial of its lead candidate Engrailed-1 at Utrecht University starting end of 2025.

Amount: $38.9M
Stage: Series B
Announced: 3 July 2025
Lead: Critical Path Ventures
Other investors: European Innovation Council (EIC Fund), iBionext, Relyens, Tudigo individual investors
Use of funds: Funds a Phase I/II ALS clinical trial of its lead candidate Engrailed-1 at Utrecht University starting end of 2025.
Checked: Announced by the company
Sources: BrainEver raises EUR 33M (MaddyMoney weekly recap) brainever.fr
BrainEver raises EUR 33M (MaddyMoney weekly recap) maddyness.com

Company

Develops neuronal reprogramming therapies for ALS and neurodegenerative diseases

Based in: Paris, France
Sector: AI
Website: brainever.fr ↗

Questions

How much has BrainEver raised?

BrainEver raised $38.9M in a Series B round, announced on 3 July 2025.

Who invested in BrainEver?

Critical Path Ventures led. Investors include Critical Path Ventures, European Innovation Council (EIC Fund), iBionext, Relyens and Tudigo individual investors.